» Articles » PMID: 18991954

Chronic Stress, Drug Use, and Vulnerability to Addiction

Overview
Specialty Science
Date 2008 Nov 11
PMID 18991954
Citations 760
Authors
Affiliations
Soon will be listed here.
Abstract

Stress is a well-known risk factor in the development of addiction and in addiction relapse vulnerability. A series of population-based and epidemiological studies have identified specific stressors and individual-level variables that are predictive of substance use and abuse. Preclinical research also shows that stress exposure enhances drug self-administration and reinstates drug seeking in drug-experienced animals. The deleterious effects of early life stress, child maltreatment, and accumulated adversity on alterations in the corticotropin releasing factor and hypothalamic-pituitary-adrenal axis (CRF/HPA), the extrahypothalamic CRF, the autonomic arousal, and the central noradrenergic systems are also presented. The effects of these alterations on the corticostriatal-limbic motivational, learning, and adaptation systems that include mesolimbic dopamine, glutamate, and gamma-amino-butyric acid (GABA) pathways are discussed as the underlying pathophysiology associated with stress-related risk of addiction. The effects of regular and chronic drug use on alterations in these stress and motivational systems are also reviewed, with specific attention to the impact of these adaptations on stress regulation, impulse control, and perpetuation of compulsive drug seeking and relapse susceptibility. Finally, research gaps in furthering our understanding of the association between stress and addiction are presented, with the hope that addressing these unanswered questions will significantly influence new prevention and treatment strategies to address vulnerability to addiction.

Citing Articles

Randomised controlled trial of LGBTQ-affirmative cognitive-behavioural therapy for sexual minority women's minority stress, mental health and hazardous drinking: Project EQuIP protocol.

Pachankis J, Chiaramonte D, Scheer J, Ankrum H, Eisenstadt B, Hobbs R BMJ Open. 2025; 15(3):e086738.

PMID: 40032395 PMC: 11877267. DOI: 10.1136/bmjopen-2024-086738.


Recent advances in understanding how compulsivity is related to behavioural addictions over their timecourse.

Solly J, Albertella L, Ioannidis K, Fineberg N, Grant J, Chamberlain S Curr Addict Rep. 2025; 12(1):26.

PMID: 40012739 PMC: 11850568. DOI: 10.1007/s40429-025-00621-2.


Neuroscience-informed psychoeducation for addiction: a conceptual and feasibility study.

Rezapour T, McLean K, Psederska E, Maleki K, Ekhtiari H, Vassileva J Front Psychiatry. 2025; 16:1527828.

PMID: 40012711 PMC: 11862476. DOI: 10.3389/fpsyt.2025.1527828.


Efficacy of Transcranial Direct Current Stimulation (tDCS) on Neuropsychiatric Symptoms in Substance Use Disorder (SUD)-A Review and Insights into Possible Mechanisms of Action.

Chmiel J, Stepien-Slodkowska M, Ramik-Mazewska I J Clin Med. 2025; 14(4).

PMID: 40004867 PMC: 11856849. DOI: 10.3390/jcm14041337.


Unveiling the Complexities of Medications, Substance Abuse, and Plants for Recreational and Narcotic Purposes: An In-Depth Analysis.

Predescu I, Jijie A, Patrascu D, Pasc A, Piros E, Trandafirescu C Pharmacy (Basel). 2025; 13(1).

PMID: 39998006 PMC: 11859396. DOI: 10.3390/pharmacy13010007.


References
1.
Widom C, Weiler B, Cottler L . Childhood victimization and drug abuse: a comparison of prospective and retrospective findings. J Consult Clin Psychol. 1999; 67(6):867-80. DOI: 10.1037//0022-006x.67.6.867. View

2.
Rohde L, Roman T, Szobot C, Cunha R, Hutz M, Biederman J . Dopamine transporter gene, response to methylphenidate and cerebral blood flow in attention-deficit/hyperactivity disorder: a pilot study. Synapse. 2003; 48(2):87-9. DOI: 10.1002/syn.10186. View

3.
Arnsten A, Li B . Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry. 2005; 57(11):1377-84. DOI: 10.1016/j.biopsych.2004.08.019. View

4.
Parsons L, Smith A, Justice Jr J . Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse. 1991; 9(1):60-5. DOI: 10.1002/syn.890090109. View

5.
Nader M, Morgan D, Gage H, Nader S, Calhoun T, Buchheimer N . PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci. 2006; 9(8):1050-6. DOI: 10.1038/nn1737. View